349 related articles for article (PubMed ID: 26965491)
1. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise.
Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S
Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491
[TBL] [Abstract][Full Text] [Related]
2. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.
Hashiesh HM; Sharma C; Goyal SN; Sadek B; Jha NK; Kaabi JA; Ojha S
Biomed Pharmacother; 2021 Aug; 140():111639. PubMed ID: 34091179
[TBL] [Abstract][Full Text] [Related]
3. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
[TBL] [Abstract][Full Text] [Related]
4. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
5. Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study.
Askari VR; Shafiee-Nick R
Biochem Pharmacol; 2019 Jan; 159():154-171. PubMed ID: 30529211
[TBL] [Abstract][Full Text] [Related]
6. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S
Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
[TBL] [Abstract][Full Text] [Related]
8. β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.
Fidyt K; Fiedorowicz A; Strządała L; Szumny A
Cancer Med; 2016 Oct; 5(10):3007-3017. PubMed ID: 27696789
[TBL] [Abstract][Full Text] [Related]
9. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038
[TBL] [Abstract][Full Text] [Related]
10. β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Aly E; Khajah MA; Masocha W
Molecules; 2019 Dec; 25(1):. PubMed ID: 31892132
[TBL] [Abstract][Full Text] [Related]
11. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
Cheng Y; Dong Z; Liu S
Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
[TBL] [Abstract][Full Text] [Related]
12. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
[TBL] [Abstract][Full Text] [Related]
13. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
[TBL] [Abstract][Full Text] [Related]
14. Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?
Meza A; Lehmann C
Med Hypotheses; 2018 Jan; 110():68-70. PubMed ID: 29317072
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of (
Scandiffio R; Geddo F; Cottone E; Querio G; Antoniotti S; Gallo MP; Maffei ME; Bovolin P
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114564
[TBL] [Abstract][Full Text] [Related]
17. Beta-caryophyllene is a dietary cannabinoid.
Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142
[TBL] [Abstract][Full Text] [Related]
18. Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.
Katsuyama S; Mizoguchi H; Kuwahata H; Komatsu T; Nagaoka K; Nakamura H; Bagetta G; Sakurada T; Sakurada S
Eur J Pain; 2013 May; 17(5):664-75. PubMed ID: 23138934
[TBL] [Abstract][Full Text] [Related]
19. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.
Bahi A; Al Mansouri S; Al Memari E; Al Ameri M; Nurulain SM; Ojha S
Physiol Behav; 2014 Aug; 135():119-24. PubMed ID: 24930711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
